WHO to take final decision next week on approval to Bharat Biotech’s Covaxin

The Emergency Use Listing process – done by WHO and the Technical Advisory Group of independent experts – is centred on determining if a manufactured product (e.g. a vaccine) is quality-assured, safe and effective, it said in another tweet.